<SEC-DOCUMENT>0001628280-23-004846.txt : 20230223
<SEC-HEADER>0001628280-23-004846.hdr.sgml : 20230223
<ACCEPTANCE-DATETIME>20230223162712
ACCESSION NUMBER:		0001628280-23-004846
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230223
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230223
DATE AS OF CHANGE:		20230223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Xencor Inc
		CENTRAL INDEX KEY:			0001326732
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				201622502
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36182
		FILM NUMBER:		23660063

	BUSINESS ADDRESS:	
		STREET 1:		111 WEST LEMON AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		626-305-5900

	MAIL ADDRESS:	
		STREET 1:		111 WEST LEMON AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>xncr-20230223.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:4735848f-decd-4bb0-bcd4-2d37d5c3caf9,g:22de1b8d-5870-4a3e-ab00-4d569b6db54e,d:7214d2571c844da6b408e2d8fe0afe45--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>xncr-20230223</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV80L2ZyYWc6MjYyYzg0ZDkxNjI1NGIwMGFmMDM4ZjBjMTE2MjcyOTkvdGFibGU6Zjc4Y2QzZjg0NmU2NDFlOWIxNGI3NWIyYmNmZGI0NGUvdGFibGVyYW5nZTpmNzhjZDNmODQ2ZTY0MWU5YjE0Yjc1YjJiY2ZkYjQ0ZV8wLTEtMS0xLTIxNTg0_e536d2ef-df1f-4bba-bf51-1ca271018180">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV80L2ZyYWc6MjYyYzg0ZDkxNjI1NGIwMGFmMDM4ZjBjMTE2MjcyOTkvdGFibGU6Zjc4Y2QzZjg0NmU2NDFlOWIxNGI3NWIyYmNmZGI0NGUvdGFibGVyYW5nZTpmNzhjZDNmODQ2ZTY0MWU5YjE0Yjc1YjJiY2ZkYjQ0ZV8xLTEtMS0xLTIxNTg0_8dc70f4e-994e-4403-8b81-3767d40d216b">0001326732</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="xncr-20230223.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001326732</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-23</xbrli:startDate><xbrli:endDate>2023-02-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7214d2571c844da6b408e2d8fe0afe45_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODcx_af4770a2-b491-4e01-b209-e36c38121eb9">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of The Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8yMTk5MDIzMjU3NDQ3_c94e6174-f52d-4278-8577-df9fe75f5e7d">February&#160;23, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODcy_34d3629d-5c96-49f9-a71d-54d52c6481f0">XENCOR,&#160;INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________________________</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.134%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6MGVmNzc3YWJlOTQwNDEwZjg4NzRmM2EzMTU2ZTZjNjEvdGFibGVyYW5nZTowZWY3NzdhYmU5NDA0MTBmODg3NGYzYTMxNTZlNmM2MV8wLTAtMS0xLTIxNTg0_642fbc5f-525c-4741-b6a0-a78e869c6b6e">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6MGVmNzc3YWJlOTQwNDEwZjg4NzRmM2EzMTU2ZTZjNjEvdGFibGVyYW5nZTowZWY3NzdhYmU5NDA0MTBmODg3NGYzYTMxNTZlNmM2MV8wLTEtMS0xLTIxNTg0_511661fb-b75f-45fb-b4c4-4a53f9d8bfdb">001-36182</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6MGVmNzc3YWJlOTQwNDEwZjg4NzRmM2EzMTU2ZTZjNjEvdGFibGVyYW5nZTowZWY3NzdhYmU5NDA0MTBmODg3NGYzYTMxNTZlNmM2MV8wLTItMS0xLTIxNTg0_840a6b8b-d764-435b-a9c8-215844d27cd8">20-1622502</ix:nonNumeric></span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(State or other jurisdiction of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Commission </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(IRS Employer </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Identification Number)</span></div></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6ZDk5MTIxMWM2ZThkNDFlYWI2NjM2OGQzMGYwNGE0YzQvdGFibGVyYW5nZTpkOTkxMjExYzZlOGQ0MWVhYjY2MzY4ZDMwZjA0YTRjNF8wLTAtMS0xLTIxNTg0L3RleHRyZWdpb246ZTE1MjBiY2JiMzIyNGVmNWFhZmQ0OGEzYjJiMzUxZDNfNQ_d943e89a-3e8d-406f-a614-768c4b74e4d0">111 West Lemon Avenue</ix:nonNumeric>  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6ZDk5MTIxMWM2ZThkNDFlYWI2NjM2OGQzMGYwNGE0YzQvdGFibGVyYW5nZTpkOTkxMjExYzZlOGQ0MWVhYjY2MzY4ZDMwZjA0YTRjNF8wLTAtMS0xLTIxNTg0L3RleHRyZWdpb246ZTE1MjBiY2JiMzIyNGVmNWFhZmQ0OGEzYjJiMzUxZDNfOQ_a433ea4d-4da7-4106-8100-02406513124a">Monrovia</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6ZDk5MTIxMWM2ZThkNDFlYWI2NjM2OGQzMGYwNGE0YzQvdGFibGVyYW5nZTpkOTkxMjExYzZlOGQ0MWVhYjY2MzY4ZDMwZjA0YTRjNF8wLTAtMS0xLTIxNTg0L3RleHRyZWdpb246ZTE1MjBiY2JiMzIyNGVmNWFhZmQ0OGEzYjJiMzUxZDNfMTM_844421e1-347a-40bb-91fd-ead8c1fdc1a6">California</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6ZDk5MTIxMWM2ZThkNDFlYWI2NjM2OGQzMGYwNGE0YzQvdGFibGVyYW5nZTpkOTkxMjExYzZlOGQ0MWVhYjY2MzY4ZDMwZjA0YTRjNF8wLTItMS0xLTIxNTg0_e639b061-8fcb-41af-873a-a015daca5169">91016</ix:nonNumeric></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODY3_0091ada2-61c3-49fa-8ade-137ef3a28d41">(626)</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODcz_3527bea2-7330-4bf2-bafa-b848bbefdd35">305-5900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________________________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see&#160;General Instruction A.2. below):</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:WrittenCommunications" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODc0_be839b01-6309-41c4-833b-016fe3888e42">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODY4_e45ae973-6131-4e73-9302-a72d70fab842">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODY5_2557c991-6d33-4fd1-ba79-4f5c5c57cb8f">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODc1_35278e32-8e37-4097-94e1-cabbb2072836">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6NDZjYzhiZmIxZjAzNGNlYWFhNmYxYjcyM2JmOTczM2IvdGFibGVyYW5nZTo0NmNjOGJmYjFmMDM0Y2VhYWE2ZjFiNzIzYmY5NzMzYl8xLTAtMS0xLTIxNTg0_86422a11-d20c-4857-a673-448fdc6b8262">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6NDZjYzhiZmIxZjAzNGNlYWFhNmYxYjcyM2JmOTczM2IvdGFibGVyYW5nZTo0NmNjOGJmYjFmMDM0Y2VhYWE2ZjFiNzIzYmY5NzMzYl8xLTEtMS0xLTIxNTg0_703a2f2e-04f2-44cf-8bf2-168bedf065de">XNCR</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6NDZjYzhiZmIxZjAzNGNlYWFhNmYxYjcyM2JmOTczM2IvdGFibGVyYW5nZTo0NmNjOGJmYjFmMDM0Y2VhYWE2ZjFiNzIzYmY5NzMzYl8xLTItMS0xLTIxNTg0_34249d16-8fd4-49b0-a460-cb7311a77f91">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODcw_8c0cad15-5e73-45cb-b9c5-19adc81300ad">o</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i7214d2571c844da6b408e2d8fe0afe45_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. Results of Operations and Financial Condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;23, 2023, Xencor, Inc. announced its financial results for the fourth quarter and fiscal year ended December&#160;31, 2022 in the press release attached hereto as Exhibit&#160;99.1 and incorporated herein by reference.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in &#8220;Item 2.02. Results of Operations and Financial Condition&#8221; of this Current Report on Form 8-K and in Exhibit 99.1 attached hereto is being furnished and shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div id="i7214d2571c844da6b408e2d8fe0afe45_13"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div style="margin-top:12pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:1.28pt">Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="xncr-202302xexx991.htm">Press Release dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="xncr-202302xexx991.htm">February 23</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="xncr-202302xexx991.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="xncr-202302xexx991.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="xncr-202302xexx991.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL).</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i7214d2571c844da6b408e2d8fe0afe45_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February&#160;23, 2023</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">XENCOR,&#160;INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Celia Eckert</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celia Eckert</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Counsel &amp; Corporate Secretary</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>xncr-202302xexx991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id22fbb03036f4498afe6059e9d6c342f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="margin-top:12pt;text-align:center"><img alt="xncr-20221107xex99d1001.jpg" src="xncr-20221107xex99d1001.jpg" style="height:56px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Xencor Reports Fourth Quarter and Full Year 2022 Financial Results</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-- Management to Host Conference Call at 4&#58;30 p.m. ET Today --</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MONROVIA, Calif.--Feb. 23, 2023-- Xencor, Inc. (NASDAQ&#58;XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a review of recent business and clinical highlights.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;In 2022, we focused on advancing our internal portfolio of XmAb</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug candidates, including the ongoing Phase 2 studies for vudalimab in combination with chemotherapy and as a monotherapy in prostate and gynecological tumors. We also advanced XmAb564, our regulatory T-cell targeting cytokine, into a multiple-ascending dose study in atopic dermatitis and psoriasis, following encouraging single-dose data that showed potentially differentiated durability at boosting target cells,&#8221; said Bassil Dahiyat, Ph.D., president and chief executive officer at Xencor. &#8220;We continue to leverage our XmAb technologies and protein engineering capabilities, both internally and with partners, to address challenging areas of biology and continually grow our portfolio. We initiated Phase 1 studies for two novel T-cell engagers, XmAb819, our 2+1 formatted CD3 bispecific for renal cell carcinoma, and XmAb808, our first internal bispecific targeting CD28, a new class of anti-tumor agent that we are at the forefront of developing.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Looking ahead, in 2023, we expect to further expand our wholly owned portfolio by initiating a Phase 1 study for XmAb662, our engineered IL-12 for oncology and our third clinical-stage cytokine using our reduced potency design. Then later this year, we anticipate submitting an IND for XmAb541, a 2+1 formatted CLDN6 x CD3 bispecific antibody that we are developing for patients with ovarian cancer.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Highlights from Xencor&#8217;s Wholly Owned Portfolio</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Vudalimab (PD-1 x CTLA-4)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two Phase 2 studies of vudalimab, a selective dual checkpoint inhibitor, are enrolling patients. Initial combination data from a study in patients with metastatic castration-resistant prostate cancer (mCRPC) were presented in November 2022, and the study continues to enroll patients under a modified chemotherapy regimen. A second study in patients with advanced gynecologic tumors and clinically defined high-risk mCRPC is also enrolling patients who will receive vudalimab as a monotherapy.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">XmAb564 (IL2-Fc)&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XmAb564 is a potency-reduced, monovalent interleukin-2 Fc fusion protein, designed to selectively activate and expand regulatory T cells (Tregs) for the potential treatment of patients with autoimmune diseases. In November 2022, Xencor presented data from a Phase 1a single-ascending dose study in healthy volunteers, demonstrating that a single dose was well tolerated and generates durable, dose-dependent and selective expansion of Tregs. A Phase 1b, multiple-ascending dose study is enrolling patients with atopic dermatitis and psoriasis and exploring multi-week dosing regimens.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">XmAb819 (ENPP3 x CD3)&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> XmAb819 is an XmAb 2+1 bispecific antibody being developed for patients with renal cell carcinoma (RCC). XmAb819 is designed to engage the immune system, activating T cells for highly potent and targeted killing of tumor cells expressing ENPP3, an antigen highly expressed on kidney cancers. Xencor&#8217;s XmAb 2+1 bispecific antibody format enables greater selectivity of ENPP3-expressing tumor cells compared to normal cells, which express lower levels of ENPP3. A Phase 1 dose-escalation study is enrolling patients with advanced RCC.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.67pt">XmAb808 (B7-H3 x CD28)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XmAb808 is a 2+1 formatted, tumor-selective, co-stimulatory CD28 bispecific antibody that binds to the broadly expressed tumor antigen B7-H3. Co-stimulatory receptor engagement is required for T cells to achieve full activation, and targeted CD28 bispecific antibodies may provide conditional co-stimulation of T cells when the antibodies are bound to tumor cells. A Phase 1 dose-escalation study in combination with pembrolizumab is now enrolling patients with advanced solid tumors.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.67pt">XmAb662 (IL12-Fc)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XmAb662 is a potency-reduced IL12-Fc fusion protein designed to increase tumor immunogenicity. Xencor&#8217;s potency-reduced approach to cytokine engineering may improve the therapeutic index and duration of action of its cytokine candidates compared to engineered cytokines with native cytokine potency. A Phase 1 study in patients with advanced solid tumors is expected to start in mid-2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Partnership Developments</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.67pt">Janssen Biotech, Inc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the first quarter of 2023, Janssen selected a CD28 bispecific antibody candidate under the companies&#8217; second collaboration agreement, which is focused on the discovery of XmAb bispecific antibodies against CD28 and B-cell targets. Janssen has an exclusive worldwide license to develop selected CD28 molecules in combination with plamotamab (CD20 x CD3) and other agents.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.67pt">Atreca, Inc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Under the companies&#8217; July 2020 agreement, a CD3 bispecific antibody program was mutually selected for further development and commercialization, with Atreca leading clinical activities and Xencor sharing 50 percent of costs and profits.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.23pt">Caris Life Sciences&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, the Company expanded its collaboration with Caris to create XmAb bispecific or multi-specific antibodies with Caris&#8217; unique human tissue bank and bioinformatics approach to find addressable tumor markers.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:9.67pt">Zenas BioPharma Ltd.&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In January 2023, Zenas dosed the first patient in a Phase 3 study evaluating obexelimab in patients with immunoglobulin G4-related disease (IgG4-RD).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On Monday, February 27, Xencor will open its Pasadena, California, laboratory and corporate headquarters, which has larger laboratories with expanded protein engineering capabilities.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Results for the Fourth Quarter and Full Year Ended December 31, 2022</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, receivables and marketable debt securities totaled $613.5&#160;million as of December&#160;31, 2022, compared to $664.1&#160;million on December&#160;31, 2021.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue for the fourth quarter ended December&#160;31, 2022 was $21.6&#160;million compared to $154.0&#160;million for the same period in 2021. Revenues earned in the fourth quarter of 2022 were primarily royalties from the </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alexion and Vir agreements and research collaboration revenue from the second Janssen agreement, compared to the same period in 2021, which were primarily from the Janssen collaboration and royalty revenue from Alexion and Vir</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenues for the full year 2022 were $164.6&#160;million compared to $275.1&#160;million for the same period in 2021. Revenues for the full year 2022 were primarily royalties from</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lexion, MorphoSys and Vir, milestone revenue from Astellas and collaboration revenue from our second Janssen collaboration, </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compared to the same period in 2021, which were earned primarily from the collaborations with Janssen and Novartis, milestone revenue from MorphoSys and royalties from Alexion and Vir.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (R&#38;D) expenses for the fourth quarter ended December&#160;31, 2022 were $51.5&#160;million and is comparable to R&#38;D expenses for the same period in 2021 which were $51.0&#160;million. R&#38;D expenses for the year ended December&#160;31, 2022 were $199.6&#160;million compared to $192.5&#160;million for the same period in 2021. Increased R&#38;D spending for the full year 2022 reflects additional spending on our CD3, CD28 and cytokine programs including XmAb808, XmAb662 and XmAb541.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative (G&#38;A) expenses for the fourth quarter ended December&#160;31, 2022 were $12.8&#160;million compared to $11.4&#160;million for the same period in 2021. G&#38;A expenses for the full year ended December&#160;31, 2022 were $47.5&#160;million compared to $38.8&#160;million for the same period in 2021. Increased G&#38;A spending for the fourth quarter and full year ended 2022 compared to amounts for the same periods in 2021 reflects additional compensation costs on general and administrative staffing, additional spending on facilities and licensing fees. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income for the fourth quarter ended December&#160;31, 2022 was $30.1&#160;million compared to other expense of $18.6&#160;million in the same period in 2021.</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other income for the fourth quarter ended December&#160;31, 2022 represents unrealized gain from the change in fair value of equity securities and interest income earned on investments. Other expenses in the same period in 2021 represents unrealized loss from the change in fair value of equity securities. Other income for the full year ended December&#160;31, 2022 was $28.0&#160;million, compared to $38.9&#160;million in the same period in 2021. Other income in 2022 reflects unrealized gain from the change in fair value of equity securities. In 2021, other income includes realized gain from the</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sale of equity securities </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $18.3 million and unrealized gains of $20.5 million from the change in fair value of equity securities.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash, stock-based compensation expense for the full year ended December&#160;31, 2022 was $48.9&#160;million compared to $37.0&#160;million for the same period in 2021.</font></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss for the fourth quarter ended December&#160;31, 2022 was $12.0&#160;million or $(0.20) on a fully diluted per share basis, compared to net income of $73.1&#160;million or $1.21 on a fully diluted per share basis, for the same period in 2021. For the full year ended December&#160;31, 2022 net loss was $55.2&#160;million or $(0.93) on a fully diluted per share basis, compared to net income of $82.6&#160;million or $1.37 on a fully diluted per share basis, for the same period in 2021. Net loss reported for the fourth quarter ended December&#160;31, 2022 compared to net income reported for the same period in 2021 is primarily due to decreased revenue reported in 2022 compared to amounts reported in 2021. Net loss for the full year 2022, compared to net income reported for the same period in 2021, is primarily due to higher revenues and realized gain on equity investments reported for the full year ended December&#160;31, 2021 compared to amounts reported for the full year ended December 31, 2022.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total shares outstanding were 59,997,713 as of December&#160;31, 2022, compared to 59,355,558 as of December&#160;31, 2021.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Guidance</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current operating plans, Xencor expects to end 2023 with between $425 million and $475 million in cash, cash equivalents, receivables and marketable debt securities, and to have cash to fund research and development programs and operations through the end of 2025.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conference</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Call and Webcast</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xencor will host a conference call today at 4&#58;30 p.m. ET (1&#58;30 p.m. PT) to discuss the full year 2022 financial results and provide a corporate update. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The live webcast will be available under &#34;Events &#38; Presentations&#34; in the Investors section of the Company's website at investors.xencor.com and will be archived for at least 30 days. Active participants in the conference call may receive credentials for telephone access by registering at the following link&#58; https&#58;&#47;&#47;register.vevent.com&#47;register&#47;BI70c60751330540e3909534dca3801239. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Upcoming Investor Conferences</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xencor management will participate at three upcoming investor conferences&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Cowen 43</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Annual Health Care Conference</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; Wednesday, March 8, 2023 </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presentation Time&#58; 12&#58;50 p.m. ET &#47; 9&#58;50 a.m. PT </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Location&#58; Boston  </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Inaugural Mizuho Oncology Therapeutics Summit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; Monday, March 13, 2023 </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Location&#58; Virtual  </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Barclays Global Healthcare Conference</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; Tuesday, March 14, 2023 </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presentation Time&#58; 2&#58;05 p.m. ET &#47; 11&#58;05 a.m. PT </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Location&#58; Miami</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Live webcasts of the Cowen and Barclays presentations will be available under &#8220;Events &#38; Presentations&#8221; in the Investors section of the Company&#8217;s website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Xencor</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements contained in this press release may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements that are not purely statements of historical fact, and can generally be identified by the use of words such as &#8220;potential,&#8221; &#8220;can,&#8221; &#8220;will,&#8221; &#8220;plan,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;seek,&#8221; &#8220;look forward,&#8221; &#8220;believe,&#8221; &#8220;committed,&#8221; &#8220;investigational,&#8221; and similar terms, or by express or implied discussions relating to Xencor&#8217;s business, including, but not limited to, statements regarding planned additional clinical trials, the quotations from Xencor's president and chief executive officer, our projected financial resources and other statements that are not purely statements of historical fact. Such statements are made on the basis of the current beliefs, expectations, and assumptions of the management of Xencor and are subject to significant known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements and the timing of events to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. Such risks include, without limitation, the risks associated with the process of discovering, developing, manufacturing and commercializing drugs that are safe and effective for use as human therapeutics and other risks, including the ability of publicly disclosed preliminary clinical trial data to support continued clinical development and regulatory approval for specific treatments, in each case as described in Xencor's public securities filings. For a discussion of these and other factors, please refer to Xencor's annual report on Form 10-K for the year ended December 31, 2021 as well as Xencor's subsequent filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended to date. All forward-looking statements are qualified in their entirety by this cautionary statement and Xencor undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof, except as required by law. </font></div><div><font><br></font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contacts</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Investors&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charles Liles</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cliles&#64;xencor.com</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">626-737-8118</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Media&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jason I. Spark</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evoke Canale</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">jason.spark&#64;evokegroup.com</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">619-849-6005</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id22fbb03036f4498afe6059e9d6c342f_4"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Xencor, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Condensed Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(in thousands)</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,942&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,480&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,689&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,767&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable equity securities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,431&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,860&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,997&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,384&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,283&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,877&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">675,342</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">424,368</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,183&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,240&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,500&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,493&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities - long term</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,826&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,465&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities - long term</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,383&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,262&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes receivable - long term</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,419&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,730&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">846,266</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">838,211</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,816&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,444&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,320&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,294&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,708&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">63,844</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,738</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,926&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,969&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118,770</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104,707</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">727,496</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">733,504</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">846,266</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">838,211</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id22fbb03036f4498afe6059e9d6c342f_7"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Xencor Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Condensed Statements of Comprehensive Income (Loss)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended December&#160;31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,610&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,016&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,579&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,111&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,452&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,988&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,563&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,507&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,751&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,375&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,489&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,837&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,203&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,363&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,052&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,344&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,593)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,653&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,473)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,767&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,136&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,592)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,965&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,864&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) before income tax</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,457)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,061&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,508)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,631&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense (benefit)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,042)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,061&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,181)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,631&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized gain (loss) on marketable securities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,924&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,435)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,442)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,584)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income (loss)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,118)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,626&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,623)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,047&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income (loss) per share</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.93)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.42&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income (loss) per share</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.93)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of common shares used in net income (loss) per share applicable to common stockholders - basic</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,912,038</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,277,543</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,652,461</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,379,641</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average number of common shares used in net income (loss) per share applicable to common stockholders - diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,912,038</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,338,462</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,652,461</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,495,455</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>xncr-20230223.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4735848f-decd-4bb0-bcd4-2d37d5c3caf9,g:22de1b8d-5870-4a3e-ab00-4d569b6db54e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xncr="http://www.xencor.com/20230223" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.xencor.com/20230223">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xncr-20230223_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="xncr-20230223_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.xencor.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>xncr-20230223_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4735848f-decd-4bb0-bcd4-2d37d5c3caf9,g:22de1b8d-5870-4a3e-ab00-4d569b6db54e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_9dd8312c-5a45-4e99-8d17-9b6bbb82f69e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ab78efed-7599-4220-b784-f08440cb1e45_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_eb553278-7b52-47e6-8e08-632f55e66d44_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b5ccb0ff-578c-4245-aa00-6d940e0a33b8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8ec2b7c0-1326-41d2-8215-4e8ddac5a7c3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_246fd2d8-81d8-4dc9-a2c3-4692edc3738a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_424bb56e-e282-410f-8f3b-0ba1b7c51e03_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_2cee2c37-d47f-4adc-bf99-8762c971967a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0e567322-a308-4a9a-8672-f2d27ef4b00d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a86848f3-1647-4431-ad92-d031a3ccbfb9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_bd291d5c-19ef-4089-ab9b-e88f733ea442_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_ba4d8bfb-0b90-4680-8140-623cee1981ca_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e305acfa-7660-48a9-a839-222479abf363_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_557ecb19-41ff-4a35-ba38-599037a6e38c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_cf507262-2e94-4aef-9e20-88e6da3d5c84_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_45c2d72b-4a8e-42e9-88d5-9617f93b2c16_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d42f6178-dca0-4b0f-bdc9-78c975668198_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_81a85626-aa77-4401-a743-22eabb68a8cf_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4af9d69d-9275-4204-a180-b9a849010191_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_91fba45d-70c1-4a72-ac1c-877d4e4b0ae9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_702b2050-64fc-44a7-8614-926e96a9e8b5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ff4fd2ce-700f-45dd-aecd-dfaf8c06e2ef_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>xncr-20230223_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4735848f-decd-4bb0-bcd4-2d37d5c3caf9,g:22de1b8d-5870-4a3e-ab00-4d569b6db54e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xencor.com/role/Cover" xlink:type="simple" xlink:href="xncr-20230223.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.xencor.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6efd043e-c555-482d-ab36-e1cd951dcb99" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_DocumentType_6efd043e-c555-482d-ab36-e1cd951dcb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0fe5881e-1709-4d39-924c-2356e0ce769b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_DocumentPeriodEndDate_0fe5881e-1709-4d39-924c-2356e0ce769b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_978caea4-b011-4945-b733-dc765d03e476" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityRegistrantName_978caea4-b011-4945-b733-dc765d03e476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c21e6cce-91e4-45c8-a8f3-6df4374daaaf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c21e6cce-91e4-45c8-a8f3-6df4374daaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_38808ace-4373-4db2-b007-6201804c1030" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityFileNumber_38808ace-4373-4db2-b007-6201804c1030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b03163f5-1f52-43a4-aa55-aaf078fed123" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityTaxIdentificationNumber_b03163f5-1f52-43a4-aa55-aaf078fed123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_310545d7-8e8e-4708-90df-3253034f7557" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityAddressAddressLine1_310545d7-8e8e-4708-90df-3253034f7557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_bcf9c769-2b29-4fd1-b291-683fbd92b7a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityAddressCityOrTown_bcf9c769-2b29-4fd1-b291-683fbd92b7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b2500bc9-9d96-48c7-823b-0de13233d9bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityAddressStateOrProvince_b2500bc9-9d96-48c7-823b-0de13233d9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9d3e2279-b0c7-4cf4-a900-f7020f6163dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityAddressPostalZipCode_9d3e2279-b0c7-4cf4-a900-f7020f6163dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6466e1a5-e268-4977-9e5b-aff33b76fed5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_CityAreaCode_6466e1a5-e268-4977-9e5b-aff33b76fed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d5510d45-3248-49ff-9a3f-eaaa7bcf4a23" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_LocalPhoneNumber_d5510d45-3248-49ff-9a3f-eaaa7bcf4a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_889cf1f3-2358-4e7e-8f26-7957a92768bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_WrittenCommunications_889cf1f3-2358-4e7e-8f26-7957a92768bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_968b7a5d-31a4-4dc5-a829-525d768f4ca9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_SolicitingMaterial_968b7a5d-31a4-4dc5-a829-525d768f4ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_dc6e2587-e184-4431-8cf3-6fa86ad2fa75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_PreCommencementTenderOffer_dc6e2587-e184-4431-8cf3-6fa86ad2fa75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_af9b355b-2f3e-4ff2-b3f9-f365a7d644b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_af9b355b-2f3e-4ff2-b3f9-f365a7d644b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_24409188-1b94-43ba-b2f5-536f4faf3fe1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_Security12bTitle_24409188-1b94-43ba-b2f5-536f4faf3fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dff00588-9229-41fa-8ef1-3a3a81961a8c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_TradingSymbol_dff00588-9229-41fa-8ef1-3a3a81961a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_dfe033b0-da67-4400-b572-0eae24ead76f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_SecurityExchangeName_dfe033b0-da67-4400-b572-0eae24ead76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f65d8966-2c62-40f4-a645-87be0c694ebf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityEmergingGrowthCompany_f65d8966-2c62-40f4-a645-87be0c694ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_13a15094-8cbd-4192-bee8-6745afb4e240" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_AmendmentFlag_13a15094-8cbd-4192-bee8-6745afb4e240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_de455002-d879-45a9-8b23-9317fdcf9678" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_528200da-3121-404b-9878-2f1cbc43228d" xlink:to="loc_dei_EntityCentralIndexKey_de455002-d879-45a9-8b23-9317fdcf9678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>xncr-20221107xex99d1001.jpg
<TEXT>
begin 644 xncr-20221107xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !1 2\# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z**3/-
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MT9I@+13<DTH- "T4W=_D4H/YT +124$T +129I,^_% #J*3-&: %HI#THS0
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MO7MD7V"QE170^"/VPOBUX'N8FC\676LVR'FTUG_248>FYOG'X-7VU\'/V%_
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MAS3_ /KYC_\ 0A7[CZ=_QX6W_7-?Y"L\?O$URG:?R/+?VKD5_P!GCQUN /\
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MQP\6)XA&K7'AS46C\NY:SMTD6Y(^ZS!B,,!QGO6.&Q/L_=GL=6.P7MK3I[G
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MPR+(%-A$,X.<?>K[1MH_(MXXLYV*%S]!BC%UH56N467X:IAU)5%N>6_M5_\
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M2JQM51Y<L#7H3YL.]#Y@^.W[8/C/XY6!TF>.#0?#^X,VGV+LQE(Z>9(>6'L
M![5S_P"SU^SWKOQZ\706=K#+;Z!!(#J.J$82).Z*>A<C@#MG)K[1\'?\$X/A
M_HEU'<:WJNK>)-AS]GD9;:%O9@@W$?\  J^H?#?A;2/"&CV^EZ+IUMI>G0+M
MCMK6,(B_@._N>:4L5"G'EHHJGE]6K/VF)9YW\:M L_"_[-/B_2=/A6WL;+P]
M/;PQK_"BQ8 _(5^/BGY?PK]N?B#X03Q_X'USPW+<O9Q:K9R6C7$:AFC#KC<
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M5],X%&!7!+$5)KE;/6IX&A2DIQCJ-"#C@4[:/2@<4M<QWA28I:* $P*,4M%
M!28I:* $HQFEHH 3%+110 F*",TM% "8%+110 F*,"EHH 3 HQ2T4 )BC&:6
MB@!.E+110 4444 )@48I:* $Q1@4M% "8%+110 5#)T-%%)C0D/2IEZ444(0
MM%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
:*** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140703581319840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 23,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XENCOR,&#160;INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1622502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">111 West Lemon Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Monrovia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">305-5900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XNCR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001326732<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>xncr-20230223_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xncr-20230223.xsd" xlink:type="simple"/>
    <context id="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001326732</identifier>
        </entity>
        <period>
            <startDate>2023-02-23</startDate>
            <endDate>2023-02-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV80L2ZyYWc6MjYyYzg0ZDkxNjI1NGIwMGFmMDM4ZjBjMTE2MjcyOTkvdGFibGU6Zjc4Y2QzZjg0NmU2NDFlOWIxNGI3NWIyYmNmZGI0NGUvdGFibGVyYW5nZTpmNzhjZDNmODQ2ZTY0MWU5YjE0Yjc1YjJiY2ZkYjQ0ZV8wLTEtMS0xLTIxNTg0_e536d2ef-df1f-4bba-bf51-1ca271018180">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV80L2ZyYWc6MjYyYzg0ZDkxNjI1NGIwMGFmMDM4ZjBjMTE2MjcyOTkvdGFibGU6Zjc4Y2QzZjg0NmU2NDFlOWIxNGI3NWIyYmNmZGI0NGUvdGFibGVyYW5nZTpmNzhjZDNmODQ2ZTY0MWU5YjE0Yjc1YjJiY2ZkYjQ0ZV8xLTEtMS0xLTIxNTg0_8dc70f4e-994e-4403-8b81-3767d40d216b">0001326732</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODcx_af4770a2-b491-4e01-b209-e36c38121eb9">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8yMTk5MDIzMjU3NDQ3_c94e6174-f52d-4278-8577-df9fe75f5e7d">2023-02-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODcy_34d3629d-5c96-49f9-a71d-54d52c6481f0">XENCOR,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6MGVmNzc3YWJlOTQwNDEwZjg4NzRmM2EzMTU2ZTZjNjEvdGFibGVyYW5nZTowZWY3NzdhYmU5NDA0MTBmODg3NGYzYTMxNTZlNmM2MV8wLTAtMS0xLTIxNTg0_642fbc5f-525c-4741-b6a0-a78e869c6b6e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6MGVmNzc3YWJlOTQwNDEwZjg4NzRmM2EzMTU2ZTZjNjEvdGFibGVyYW5nZTowZWY3NzdhYmU5NDA0MTBmODg3NGYzYTMxNTZlNmM2MV8wLTEtMS0xLTIxNTg0_511661fb-b75f-45fb-b4c4-4a53f9d8bfdb">001-36182</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6MGVmNzc3YWJlOTQwNDEwZjg4NzRmM2EzMTU2ZTZjNjEvdGFibGVyYW5nZTowZWY3NzdhYmU5NDA0MTBmODg3NGYzYTMxNTZlNmM2MV8wLTItMS0xLTIxNTg0_840a6b8b-d764-435b-a9c8-215844d27cd8">20-1622502</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6ZDk5MTIxMWM2ZThkNDFlYWI2NjM2OGQzMGYwNGE0YzQvdGFibGVyYW5nZTpkOTkxMjExYzZlOGQ0MWVhYjY2MzY4ZDMwZjA0YTRjNF8wLTAtMS0xLTIxNTg0L3RleHRyZWdpb246ZTE1MjBiY2JiMzIyNGVmNWFhZmQ0OGEzYjJiMzUxZDNfNQ_d943e89a-3e8d-406f-a614-768c4b74e4d0">111 West Lemon Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6ZDk5MTIxMWM2ZThkNDFlYWI2NjM2OGQzMGYwNGE0YzQvdGFibGVyYW5nZTpkOTkxMjExYzZlOGQ0MWVhYjY2MzY4ZDMwZjA0YTRjNF8wLTAtMS0xLTIxNTg0L3RleHRyZWdpb246ZTE1MjBiY2JiMzIyNGVmNWFhZmQ0OGEzYjJiMzUxZDNfOQ_a433ea4d-4da7-4106-8100-02406513124a">Monrovia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6ZDk5MTIxMWM2ZThkNDFlYWI2NjM2OGQzMGYwNGE0YzQvdGFibGVyYW5nZTpkOTkxMjExYzZlOGQ0MWVhYjY2MzY4ZDMwZjA0YTRjNF8wLTAtMS0xLTIxNTg0L3RleHRyZWdpb246ZTE1MjBiY2JiMzIyNGVmNWFhZmQ0OGEzYjJiMzUxZDNfMTM_844421e1-347a-40bb-91fd-ead8c1fdc1a6">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6ZDk5MTIxMWM2ZThkNDFlYWI2NjM2OGQzMGYwNGE0YzQvdGFibGVyYW5nZTpkOTkxMjExYzZlOGQ0MWVhYjY2MzY4ZDMwZjA0YTRjNF8wLTItMS0xLTIxNTg0_e639b061-8fcb-41af-873a-a015daca5169">91016</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODY3_0091ada2-61c3-49fa-8ade-137ef3a28d41">(626)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODcz_3527bea2-7330-4bf2-bafa-b848bbefdd35">305-5900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODc0_be839b01-6309-41c4-833b-016fe3888e42">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODY4_e45ae973-6131-4e73-9302-a72d70fab842">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODY5_2557c991-6d33-4fd1-ba79-4f5c5c57cb8f">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODc1_35278e32-8e37-4097-94e1-cabbb2072836">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6NDZjYzhiZmIxZjAzNGNlYWFhNmYxYjcyM2JmOTczM2IvdGFibGVyYW5nZTo0NmNjOGJmYjFmMDM0Y2VhYWE2ZjFiNzIzYmY5NzMzYl8xLTAtMS0xLTIxNTg0_86422a11-d20c-4857-a673-448fdc6b8262">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6NDZjYzhiZmIxZjAzNGNlYWFhNmYxYjcyM2JmOTczM2IvdGFibGVyYW5nZTo0NmNjOGJmYjFmMDM0Y2VhYWE2ZjFiNzIzYmY5NzMzYl8xLTEtMS0xLTIxNTg0_703a2f2e-04f2-44cf-8bf2-168bedf065de">XNCR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGFibGU6NDZjYzhiZmIxZjAzNGNlYWFhNmYxYjcyM2JmOTczM2IvdGFibGVyYW5nZTo0NmNjOGJmYjFmMDM0Y2VhYWE2ZjFiNzIzYmY5NzMzYl8xLTItMS0xLTIxNTg0_34249d16-8fd4-49b0-a460-cb7311a77f91">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMTRkMjU3MWM4NDRkYTZiNDA4ZTJkOGZlMGFmZTQ1L3NlYzo3MjE0ZDI1NzFjODQ0ZGE2YjQwOGUyZDhmZTBhZmU0NV8xL2ZyYWc6MGQ1YWViZmI3YmZiNDk3ZDgyYjllMzBhM2E1ZWEwMTQvdGV4dHJlZ2lvbjowZDVhZWJmYjdiZmI0OTdkODJiOWUzMGEzYTVlYTAxNF8xODcw_8c0cad15-5e73-45cb-b9c5-19adc81300ad">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ 8X-75I>*NQS
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M7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ 8X-75B0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !C@U=68$LL*.X    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !C
M@U=6F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( &.#5U9<[-';0P0  'P0   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !C
M@U=6GZ ;\+$"  #B#   #0              @ &&#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( &.#5U:7BKL<P    !,"   +              "  6(/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( &.#5U:JQ"(6,P$  "("   /
M          "  4L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !C@U=6
M)!Z;HJT   #X 0  &@              @ &K$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " !C@U=699!YDAD!  #/ P  $P
M        @ &0$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  #:$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="xncr-20230223.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.xencor.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="xncr-20230223.htm">xncr-20230223.htm</File>
    <File>xncr-20230223.xsd</File>
    <File>xncr-20230223_lab.xml</File>
    <File>xncr-20230223_pre.xml</File>
    <File>xncr-202302xexx991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "xncr-20230223.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "xncr-20230223.htm"
     ]
    },
    "labelLink": {
     "local": [
      "xncr-20230223_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xncr-20230223_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "xncr-20230223.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "xncr",
   "nsuri": "http://www.xencor.com/20230223",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "xncr-20230223.htm",
      "contextRef": "icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.xencor.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "xncr-20230223.htm",
      "contextRef": "icd7ed7df23664a3b96e05c67a9d2705e_D20230223-20230223",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.xencor.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-23-004846-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-004846-xbrl.zip
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M\OMD< XPRX,OYN5!KY&VC^3900_Z[IW)IUQ3=$8X2"</>T(Z4>1X&D;8I<3
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M=1N?.]W>"Z)D/7 _3^-D2L-42B/IB+O"L<T9'"M2%$M8VV+O-GX2D2?UAES
M/XW]U(>.&S-W""8JE_;<5()B;"GJ!I'2>NPB+#H!?)=/HCB5MI;/G()-QY-4
MXA<B6!5GQ9R]JRYG^!):.Z>:9U,.GS,#MY&;O;<# PR^06,8<RB:(4;G: Y+
MAGCX[](F,)=SK5UO+<1\[/JA<NJ"+ZAC0T6>1AA2B6$B4S,,Q#S+XX;F:=P
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M+N\K]+5/:^G;2.("^U<_F\Q/^@7F\2O@HIS-X<$S]:]>?&-9?2KI_1+3J44
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M,9]SCOCB-[_=+>;>3U$M\[)X.PE>^1-/%*SD>7'Y=O+MX@/ D]].7KQX\Q<
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MCBQ;0_^M1*KUU4F8;4N#B5'KP+8 ]0U<L^V'?"[6A2$6#-*$^2 (80Q0P"'
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M$Q3+_JZ'8=,V/K9+Q2VJE3QJQ1F15 ;BK+&$9Q9#E()SFQY.N'-X@Q[W =A
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M1^$7J@=9"5@*?=?Q8AQ65<7 AJ[M41XAAD4%O!]I&\+!DR)@DGM!,BD79N!
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M'VW>((A)<5$SG],_WKSKF%[;[+0LQS%;KBF<GMEK.:[O<:=K6K;3JX3H+#<
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MFKHG2Q!=CEF>>)086/O3+YH/,NH\!L*A#KMCUH_ D[+3:)2B^4YD^;U1I=N
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MF#0@M"VK(*J R2\0S7IKKES=9TTH6H@BI+.ND&%'S@ H3D Z$:RL'-E1^[0
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M>0) 72?U",9 KUTGU"G?#F17EWOC,JHM@,N)T^ZT#,<M,JK[T('[;92;<>&
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MS)P^POM)A#9QX1%%BU<O^S@+/2WZ>.;/?N1/X#_#=!2\^A]02P$"% ,4
M" !C@U=6?E#6D2P4  ##A@  $0              @ $     >&YC<BTR,#(S
M,#(R,RYH=&U02P$"% ,4    " !C@U=6UC.8/V4"  !H!P  $0
M    @ %;%   >&YC<BTR,#(S,#(R,RYX<V102P$"% ,4    " !C@U=6,>8+
MV4L*   870  %0              @ 'O%@  >&YC<BTR,#(S,#(R,U]L86(N
M>&UL4$L! A0#%     @ 8X-75A%_OU&I!@  V#   !4              ( !
M;2$  'AN8W(M,C R,S R,C-?<')E+GAM;%!+ 0(4 Q0    ( &.#5U8+ D/G
MT20  +*E 0 6              "  4DH  !X;F-R+3(P,C,P,GAE>'@Y.3$N
9:'1M4$L%!@     %  4 2 $  $Y-      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
